Literature DB >> 10742113

Mutations in Sox18 underlie cardiovascular and hair follicle defects in ragged mice.

D Pennisi1, J Gardner, D Chambers, B Hosking, J Peters, G Muscat, C Abbott, P Koopman.   

Abstract

Analysis of classical mouse mutations has been useful in the identification and study of many genes. We previously mapped Sox18, encoding an SRY-related transcription factor, to distal mouse chromosome 2. This region contains a known mouse mutation, ragged (Ra), that affects the coat and vasculature. Here we have directly evaluated Sox18 as a candidate for Ra. We found that Sox18 is expressed in the developing vascular endothelium and hair follicles in mouse embryos. Furthermore, we found no recombination between Sox18 and Ra in an interspecific backcross segregating for the Ra phenotype. We found point mutations in Sox18 in two different Ra alleles that result in missense translation and premature truncation of the encoded protein. Fusion proteins containing these mutations lack the ability to activate transcription relative to wild-type controls in an in vitro assay. Our observations implicate mutations in Sox18 as the underlying cause of the Ra phenotype, and identify Sox18 as a critical gene for cardiovascular and hair follicle formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10742113     DOI: 10.1038/74301

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  64 in total

1.  Mice null for sox18 are viable and display a mild coat defect.

Authors:  D Pennisi; J Bowles; A Nagy; G Muscat; P Koopman
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells.

Authors:  R Sathish Srinivasan; Xin Geng; Ying Yang; Yingdi Wang; Suraj Mukatira; Michèle Studer; Marianna P R Porto; Oleg Lagutin; Guillermo Oliver
Journal:  Genes Dev       Date:  2010-04-01       Impact factor: 11.361

Review 3.  Current views on the function of the lymphatic vasculature in health and disease.

Authors:  Yingdi Wang; Guillermo Oliver
Journal:  Genes Dev       Date:  2010-10-01       Impact factor: 11.361

Review 4.  Biomarkers of lymphatic function and disease: state of the art and future directions.

Authors:  Kenta Nakamura; Stanley G Rockson
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

Review 5.  The lymphatic system in health and disease.

Authors:  Leah N Cueni; Michael Detmar
Journal:  Lymphat Res Biol       Date:  2008       Impact factor: 2.589

Review 6.  From germline towards somatic mutations in the pathophysiology of vascular anomalies.

Authors:  Nisha Limaye; Laurence M Boon; Miikka Vikkula
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

7.  SoxF factors induce Notch1 expression via direct transcriptional regulation during early arterial development.

Authors:  Ivy Kim-Ni Chiang; Martin Fritzsche; Cathy Pichol-Thievend; Alice Neal; Kelly Holmes; Anne Lagendijk; Jeroen Overman; Donatella D'Angelo; Alice Omini; Dorien Hermkens; Emmanuelle Lesieur; Ke Liu; Indrika Ratnayaka; Monica Corada; George Bou-Gharios; Jason Carroll; Elisabetta Dejana; Stefan Schulte-Merker; Benjamin Hogan; Monica Beltrame; Sarah De Val; Mathias Francois
Journal:  Development       Date:  2017-06-15       Impact factor: 6.868

8.  Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells.

Authors:  Izuagie Attairu Ikhapoh; Christopher J Pelham; Devendra K Agrawal
Journal:  Differentiation       Date:  2015-04-23       Impact factor: 3.880

9.  Genetics of dark skin in mice.

Authors:  Karen R Fitch; Kelly A McGowan; Catherine D van Raamsdonk; Helmut Fuchs; Daekee Lee; Anne Puech; Yann Hérault; David W Threadgill; Martin Hrabé de Angelis; Gregory S Barsh
Journal:  Genes Dev       Date:  2003-01-15       Impact factor: 11.361

Review 10.  Vascular anomalies: from genetics toward models for therapeutic trials.

Authors:  Melanie Uebelhoer; Laurence M Boon; Miikka Vikkula
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.